As of 2025-07-05, the EV/EBITDA ratio of Regenxbio Inc (RGNX) is -2.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGNX's latest enterprise value is 308.29 mil USD. RGNX's TTM EBITDA according to its financial statements is -141.37 mil USD. Dividing these 2 quantities gives us the above RGNX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 14.1x | 13.6x |
| Forward P/E multiples | 23.0x - 32.2x | 26.6x |
| Fair Price | (62.23) - (37.26) | (54.05) |
| Upside | -812.0% - -526.3% | -718.5% |
| Date | EV/EBITDA |
| 2025-07-03 | -2.18 |
| 2025-07-02 | -2.14 |
| 2025-07-01 | -2.00 |
| 2025-06-30 | -1.99 |
| 2025-06-27 | -2.06 |
| 2025-06-26 | -2.18 |
| 2025-06-25 | -2.11 |
| 2025-06-24 | -2.12 |
| 2025-06-23 | -1.87 |
| 2025-06-20 | -2.07 |
| 2025-06-18 | -2.12 |
| 2025-06-17 | -2.15 |
| 2025-06-16 | -2.33 |
| 2025-06-13 | -2.37 |
| 2025-06-12 | -2.70 |
| 2025-06-11 | -2.70 |
| 2025-06-10 | -2.56 |
| 2025-06-09 | -2.46 |
| 2025-06-06 | -2.49 |
| 2025-06-05 | -2.05 |
| 2025-06-04 | -2.66 |
| 2025-06-03 | -2.67 |
| 2025-06-02 | -2.75 |
| 2025-05-30 | -2.22 |
| 2025-05-29 | -2.26 |
| 2025-05-28 | -2.11 |
| 2025-05-27 | -2.30 |
| 2025-05-23 | -2.53 |
| 2025-05-22 | -2.58 |
| 2025-05-21 | -2.50 |
| 2025-05-20 | -2.63 |
| 2025-05-19 | -2.55 |
| 2025-05-16 | -2.23 |
| 2025-05-15 | -2.15 |
| 2025-05-14 | -2.04 |
| 2025-05-13 | -1.98 |
| 2025-05-12 | -1.91 |
| 2025-05-09 | -1.75 |
| 2025-05-08 | -1.62 |
| 2025-05-07 | -1.65 |
| 2025-05-06 | -1.89 |
| 2025-05-05 | -2.54 |
| 2025-05-02 | -2.77 |
| 2025-05-01 | -2.57 |
| 2025-04-30 | -2.49 |
| 2025-04-29 | -2.42 |
| 2025-04-28 | -2.32 |
| 2025-04-25 | -2.33 |
| 2025-04-24 | -2.34 |
| 2025-04-23 | -2.23 |